fid-na-131-i-t 37-5500 mbq
national centre for nuclear research - polonia - natrii iodidum (131i) - caps. pt. uz terapeutic - 37-5500mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131
sunitinib sandoz 37,5 mg
remedica ltd - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 37,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
asikreba 37,5 mg
pharmadox healthcare ltd. - malta - sunitinibum - caps. - 37,5 mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib zentiva 37,5 mg
remedica ltd - cipru - sunitinibum - caps. - 37,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
teurlata 37,5 mg
pharmadox healthcare ltd. - malta - sunitinibum - caps. - 37,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib msn 37,5 mg
pharmadox healthcare limited - malta - sunitinibum - caps. - 37,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
venlafaxina aurobindo 37,5 mg
apl swift services (malta) limited - malta - venlafaxinum - caps. elib. prel. - 37,5mg - antidepresive alte antidepresive
efectin ep 37,5 mg
pfizer manufacturing deutschland gmbh - germania - venlafaxinum - caps. elib. prel. - 37,5 mg - antidepresive alte antidepresive
venlafaxina aurobindo 37,5 mg
apl swift services (malta) limited - malta - venlafaxinum - caps. cu elib. prel. - 37,5mg - antidepresive alte antidepresive